Povorcitinib 75 mg achieved high-threshold lesion clearance by week 12, including 100% draining-tunnel reduction in 12%–57% and total abscess clearance in 22%–62% of participants. Phase 3 data show ...
CHOP receives $10 million grant for project that uses clinical data analysis to combat rare diseases
The Center for Data Driven Discovery in Biomedicine at the Children's Hospital of Philadelphia received a $10 million federal grant for the development of Real-time Analysis and Discovery in ...
Keros Therapeutics, Inc. ('Keros” or the 'Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on ...
Cancer patients' messages about radiology/pathology reports: Insights for AI. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component ...
As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
A research team has developed a versatile machine learning model that could one day greatly expand what medical scans can tell us about disease. Scientists used their tool, named Merlin, to assess 3D ...
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results